AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $50,805,453 | 76.58% |
| TFG Asset Management GP Ltd | 12,000,000 | $28,560,000 | 3.86% |
| Paradigm Biocapital Advisors LP | 9,217,150 | $21,936,817 | 1.70% |
| Deep Track Capital, LP | 15,000,000 | $35,700,000 | 1.65% |
| Affinity Asset Advisors, LLC | 1,589,017 | $3,781,860 | 1.32% |
| Nantahala Capital Management | 4,272,203 | $10,167,843 | 0.98% |
| DAFNA Capital Management LLC | 930,394 | $2,214,338 | 0.60% |
| Odey Asset Management LLP | 658,995 | $1,568,408 | 0.58% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,917,520 | 0.53% |
| ARMISTICE CAPITAL, LLC | 7,264,000 | $17,288,320 | 0.25% |